相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells
Francesco Neri et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability
Susan C. Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
S. Fujii et al.
ONCOGENE (2011)
Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
Cheryl M. Koh et al.
ONCOTARGET (2011)
Deregulation of H3K27 methylation in cancer
Eva Martinez-Garcia et al.
NATURE GENETICS (2010)
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
Junxia Min et al.
NATURE MEDICINE (2010)
Quantitative, Architectural Analysis of Immune Cell Subsets in Tumor-Draining Lymph Nodes from Breast Cancer Patients and Healthy Lymph Nodes
A. Francesca Setiadi et al.
PLOS ONE (2010)
Epigenetic contributions to cancer metastasis
David I. Rodenhiser
CLINICAL & EXPERIMENTAL METASTASIS (2009)
A gene expression signature that defines breast cancer metastases
Rachel E. Ellsworth et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Tissue specificity and the human protein interaction network
Alice Bossi et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
STRING 8-a global view on proteins and their functional interactions in 630 organisms
Lars J. Jensen et al.
NUCLEIC ACIDS RESEARCH (2009)
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sandrine Sander et al.
BLOOD (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Breast cancer metastases are molecularly distinct from their primary tumors
M. Vecchi et al.
ONCOGENE (2008)
Differential cadherin expression: Potential markers for epithelial to mesenchymal transformation during tumor progression
Georgia Agiostratidou et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2007)
Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients
Yumei Feng et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Gene expression network analysis and applications to immunology
Serban Nacu et al.
BIOINFORMATICS (2007)
Epigenetic stem cell signature in cancer
Martin Widschwendter et al.
NATURE GENETICS (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
Analysis of the E-cadherin repressor snail in primary human cancers
K.-F. Becker et al.
CELLS TISSUES ORGANS (2007)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
B Weigelt et al.
CANCER RESEARCH (2005)
c-Myc-regulated microRNAs modulate E2F1 expression
KA O'Donnell et al.
NATURE (2005)
Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis
M Shinozaki et al.
CLINICAL CANCER RESEARCH (2005)
Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis
XS Hao et al.
CANCER (2004)
Gene expression profiles of primary breast tumors maintained in distant metastases
B Weigelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)